Faculty

DISCLOSURE POLICY

The faculty, committee members, and staff who are in position to control the content of this activity are required to disclose to the Endocrine Society and to learners any relevant financial relationship(s) of the individual or spouse/partner that have occurred within the last 12 months with any commercial interest(s) whose products or services are related to the CME content. Financial relationships are defined by remuneration in any amount from the commercial interest(s) in the form of grants; research support; consulting fees; salary; ownership interest (e.g., stocks, stock options, or ownership interest excluding diversified mutual funds); honoraria or other payments for participation in speakers' bureaus, advisory boards, or boards of directors; or other financial benefits. The intent of this disclosure is not to prevent CME planners with relevant financial relationships from planning or delivery of content, but rather to provide learners with information that allows them to make their own judgments of whether these financial relationships may have influenced the educational activity with regard to exposition or conclusion.

The Endocrine Society has reviewed all disclosures and resolved or managed all identified conflicts of interest, as applicable.

The following faculty reported no relevant financial relationships during the content development process for this activity:

The faculty reported the following relevant financial relationship(s) during the content development process for this activity:
John P. Bilezikian: Advisor Group, Shire, Radius, Ultragenyx, Amgen; Ad Hoc Consultant: Lilly. 
Richard Eastell, MD, FRCP, FRCPath, FMedSci: Consulting Fee, Amgen Inc, Alexion Pharmaceuticals, Inc. Grant Recipient, Amgen Inc, Alexion Pharmaceuticals, Inc., Immunodiagnostic Systems
Benjamin Zev Leder, MD: Advisory Board Member, Amgen Inc., Radius Health, Inc. Grant Recipient, Amgen Inc, Lilly USA, LLC
Bart L. Clarke, MD: Consultant, Amgen Inc.; Bristol-Myers Squibb; Research support, Shire

The following SPC member who planned and reviewed content for this activity reported  relevant financial relationships: 
Natalie Cusano, MD: Research Support, Shire; Speaker, Shire

The following SPC members reported relevant financial relationships:
Zahid Ahmad, MD: Research Support, Regeneron, FH Foundation; Consultant, Regeneron; Speaker, Amgen, Genzyme, Sanofi
Andrew Ahmann, MD: Research Support, DexCom, Lexicon, Medtronic, Novo Nordisk; Consultant, Dexcom, Novo Nordisk, Trividia Health
Giuseppe Barbesino, MD: Spouse, employee of Genzyme
John Carmichael, MD: Research Support, Novo Nordisk, Chiasma, Novartis, Pfizer, Strongbridge Biopharma; Speaker, Novartis; Advisory Board, Pfizer, Chiasma, Ionis Pharmaceuticals
Natalie Cusano, MD: Research Support, Shire; Speaker, Shire
Joan Han, MD: Research Support, Rhythm Pharmaceutical
Steven T. Harris, MD: Ad hoc consultant on Advisory Boards, Eli Lilly & Company, Merck, Radius Health; Speaker, Amgen, Eli Lilly & Company, Radius Health, Shire
Alan Kelly, MD: Speaker, Eli Lilly
Jonathan Purnell, MD: Advisor, Novo Nordisk
Neda Rasouli, MD: Research Support, Novo Nordisk, Calibra, INTARCIA Therapeutics, GlaxoSmithKline, Bristol Meyer Squibb, AstraZeneca /Amylin, Ionis Pharmaceuticals, Boehringer Ingelheim

The Endocrine Society has reviewed these relationships to determine which are relevant to the content of this activity and resolved any identified conflicts of interest for these individuals.

The following SPC members reported no relevant financial relationships:
Amy Rothberg, MD, Susmeeta Sharma, MD

Endocrine Society staff associated with the development of content for this activity reported no relevant financial relationships.